Study details
Enrolling now
Positron Emission Tomography (PET) Imaging of Thrombosis
Massachusetts General Hospital
NCT IDNCT03830320ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
165
Study length
about 9.8 years
Ages
18–85
Locations
1 site in MA
About this study
This trial is testing a new radiotracer called 64Cu-FBP8 for PET-MR imaging to detect thrombosis. The tracer has the potential to find clots anywhere in the body, offering a non-invasive way to check for them compared to current methods.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take [64Cu]FBP8
- 2.Undergo Blood Collection
- 3.Undergo Electrocardiogram
- +1 more
PhasePhase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
diagnostic
Body systems
Cardiology / Heart, Oncology, Infectious